BNET Industries
Market Cap:$149.2B
Last Fiscal Year Sales:$48.4B
- Public
- US
Dow Jones Description
Taking care of you and your four-legged friends too! Pfizer Inc. (NYSE: PFE), based in New York, NY, discovers, develops, manufactures and sells prescription medications for humans and animals. Employing about 115,000 people, this $51.3 billion company operates in three segments: Human Health, Consumer Healthcare and Animal Health. Together, these segments cover treatments for diseases such as cardiovascular and metabolic diseases, medications for oral care, tobacco dependence, and products for prevention and treatment of diseases in livestock and pets.
Number of Employees 81,800
Peer Companies
NAICS Code Pharmaceutical Preparation Manufacturing: 325412
Recent Events
-
Bristol-Myers Squibb Raises Exchange Offer Price For Mead Johnson Shares - Update
-
'IT boosts efficiency & innovation'
-
Inspector General Saved Billions in Healthcare This Year
-
Pfizer and B.C. launch $9M collaboration to tackle cancer
-
Reportlinker Adds Growth Factors Blood And Tissue - A World Report
-
Pfizer signs agreement with Protalix BioTherapeutics for Taliglucerase alfa
-
Pfizer Inc. PFE JOBS Acquires Rights to Protalix Biotherapeutics's Gaucher Drug in Deal Worth $115M
-
Roche's Merger Formula for Genentech
-
Pfizer PFE Will Not Renew Ethical Distribution Agreement Term with MWI Veterinary Supply MWIV
-
Pfizer Inc. and Wyeth; Analysis of Agreement Containing Consent Order To Aid Public Comment and...
-
A 2nd Loss for Pfizer in Drug Suits
-
Pfizer acquires stem cell therapies assets of Axordia
-
Standpoint Raised Its FY10 Price Target on Pfizer PFE to $24
-
ImmunoVaccine signs exclusive licence deal with Pfizer
-
Pfizer Animal Health selects Bader Rutter as agency of record
-
FDA panel backs Pfizer's anti-infection vaccine for kids
-
Cash Just Kept On Piling Up, But It Looks Like The Spending Has Started
-
Goldman Sachs Said Pfizer PFE Best Positioned US Pharma in China
News & Analysis
Filter by
manufacturing and pfizer inc. - All News and Analysis
Pfizer's Jet Sale: Downsizing or Upscaling? Wyeth Brings Its Own
BNET
- 2009-06-09
Pfizer may not be getting rid of its private aircraft (complete with their gold-tassled throw cushions) after all. A column in The Day says that the company is re-evaluating its options in light of the Wyeth merger. by Jim Edwards
A Look Inside Pfizer's Corporate Jets, Now Up for Sale
BNET
- 2009-06-02
Pfizer is selling two of its corporate jets for $65 million. This is a popular move among drug companies -- putting the private aircraft up for sale makes you look more frugal and less excessive in a recession. by Jim Edwards
Solvay, Pfizer, Sanofi Join Merck in Abandoning Obesity Drugs
BNET
- 2008-11-05
For those of you hoping that America’s obesity crisis could be solved with a pill, think again. Pfizer announced late Wednesday that it is scrapping its anti-fat drug, the as-yet unnamed “CP-945,598,†for essentially political reasons. Sanofi-Aventis today also announced that it was ending its trials on Acomplia/Zimulti, an obesity...
Pfizer Japan Receives Manufacturing and Marketing Authorization for SUTENT
- 2008-04-21
For the Treatment of Two Difficult-to-Treat Advanced Cancers
Pfizer Japan Receives Manufacturing and Marketing Authorization for Champix®
- 2008-01-29
The First Oral Smoking Cessation Aid in Japan
Iceland's Actavis Group acquires Pfizer's manufacturing site in Italy
- 2008-01-18
NORDIC BUSINESS REPORT-18 January 2008-Iceland's Actavis Group acquires Pfizer's manufacturing site in ItalyC1994-2008 M2 COMMUNICATIONS LTD http://www.m2.com
PharmEng Completes Acquisition of Pfizer Manufacturing Facility, Announces Closing of $20 Million Debt Financing and Full Payout of Amounts Owing to Shropshire S.a.r.L.
- 2007-12-31
TORONTO, ONTARIO, Dec 31, 2007 Marketwire via COMTEX -- PharmEng International Inc. (TSX VENTURE:PII), announced today that its subsidiary, Keata Pharma Inc., has completed its agreement with Pfizer Canada to acquire Pfizer's manufacturing facility TORONTO, ONTARIO, Dec 31, 2007 Marketwire via COMTEX -- PharmEng International...
PharmEng Announces Purchase of Pfizer Manufacturing Facility in Arnprior, Ont.
- 2007-12-19
TORONTO, ONTARIO, Dec 19, 2007 Marketwire via COMTEX -- PharmEng International Inc. (TSX VENTURE:PII), announced today that its subsidiary, Keata Pharma Inc., has entered into an agreement with Pfizer Canada for Keata to purchase Pfizer's manufactu TORONTO, ONTARIO, Dec 19, 2007 Marketwire via COMTEX -- PharmEng...
Pfizer to close UK manufacturing facility
- 2007-10-01
UKUK
Abraxis Bioscience Completes Acquisition of Manufacturing Complex from Pfizer
- 2007-02-14
State-of-the-Art Puerto Rico Facility Supplements Abraxis' Manufacturing Capabilities to Support Expansion of its Injectables Portfolio
Industry Transcripts by Seeking Alpha
-
Avanir Pharmaceuticals F4Q09 (Qtr End 09/30/2009) Earnings Call Transcript
on Nov 24, 2009about AVNR
-
Palatin Technologies F1Q10 (Qtr End 9/30/09) Earnings Call Transcript
on Nov 16, 2009about PTN
-
Flamel Technologies SA Q3 2009 Earnings Call Transcript
on Nov 16, 2009about FLML
-
NexMed Inc. Q3 2009 Earnings Call Transcript
on Nov 10, 2009about NEXM
-
InterMune, Inc. Q3 2009 Earnings Call Transcript
on Nov 10, 2009about ITMN
IndustryTop Rated
- How NOT to Write a Biotech Press Release: Just Ask Epeius 5 votes
- Teva, In Turnabout, Sues to Protect Its Multiple Sclerosis Drug Copaxone 3 votes
- Fired Whistleblower Reps Make Similar Claim: Pfizer Said They Lacked "Integrity" 3 votes
- More Tysabri Problems; Time for a Biogen-Idec Credibility Check 3 votes
- Biogen Idec's Social Media Ties Save Tysabri Again; FDA Watching 3 votes
